Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prima BioMed Ltd (NASDAQ:PBMD)

1.55
Delayed Data
As of Aug 18
 +0.03 / +1.97%
Today’s Change
1.40
Today|||52-Week Range
3.26
-33.76%
Year-to-Date
Institutional investors purchased a net $1.0 million shares of PBMD during the quarter ended December 2016, and now own 4.45% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders--
Individual stakeholders--
Other institutional--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

6/30/2017SABBY CAPITAL LLC  Bought 962.8 Thousand shares of Prima BioMed Ltd
6/30/2017KCG AMERICAS LLC  Bought 34.6 Thousand shares of Prima BioMed Ltd
6/30/2017CITADEL ADVISORS LLC  Bought 10.3 Thousand shares of Prima BioMed Ltd

Top 10 Owners of Prima BioMed Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Sabby Capital LLC4.11%962,8351,530,908+962,835--
KCG Americas LLC0.15%34,63855,074+34,638--
Citadel Advisors LLC0.04%10,28516,353+10,285--
Hallmark Capital Management, Inc.0.04%10,00015,90000.00%
Waters, Parkerson & Co. LLC0.04%10,00015,900+10,000--
UBS Securities LLC0.03%7,93912,623+2,391+43.10%
BMO Asset Management, Inc.0.03%6,0009,54000.00%
Tower Research Capital LLC0.00%00-100-100.00%
Creative Planning, Inc.0.00%00-10-100.00%

Top 10 Mutual Funds Holding Prima BioMed Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change